TRIM21 and cancer: Taken altogether, we proposed a putative model in which HHT blocks the interaction between CDK2 and Cyclin A. This enhances interactions between CDK2 and Trim21, which recruits autophagic machinery to degrade CDK2 in cancer cells (Fig. 6F).